Search research articles
Contact Us
Filters
Showing results (41-50 of 185) with videos related to
Page
of 19
Sort By:
Frontiers in Immunology
|
April 19, 2021
High Throughput Multi-Omics Approaches for Clinical Trial Evaluation and Drug Discovery
Jessica M Zielinski, Jason J Luke, Silvia Guglietta, et al.
Journal for Immunotherapy of Cancer
|
June 23, 2016
Single dose denileukin diftitox does not enhance vaccine-induced T cell responses or effectively deplete Tregs in advanced melanoma: immune monitoring and clinical results of a randomized phase II trial
Jason J Luke, Yuanyuan Zha, Karen Matijevich, et al.
Cancer Immunology Research
|
September 6, 2018
T Cell-Inflamed versus Non-T Cell-Inflamed Tumors: A Conceptual Framework for Cancer Immunotherapy Drug Development and Combination Therapy Selection
Jonathan A Trujillo, Randy F Sweis, Riyue Bao, et al.
Nature Reviews. Clinical Oncology
|
April 5, 2017
Targeted agents and immunotherapies: optimizing outcomes in melanoma
Jason J Luke, Keith T Flaherty, Antoni Ribas, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
January 18, 2024
Facts and Hopes in Using Omics to Advance Combined Immunotherapy Strategies
Ryan C Augustin, Wesley L Cai, Jason J Luke, et al.
Nature Reviews. Clinical Oncology
|
April 26, 2022
Optimal systemic therapy for high-risk resectable melanoma
Alexander M M Eggermont, Omid Hamid, Georgia V Long, et al.
International Journal of Breast Cancer
|
June 5, 2018
The Evolution of Radiation Therapy in Metastatic Breast Cancer: From Local Therapy to Systemic Agent
Jessica M S Jutzy, Jeffrey M Lemons, Jason J Luke, et al.
Journal of Immunotherapy (Hagerstown, Md. : 1997)
|
January 8, 2019
Facial Palsy Induced by Checkpoint Blockade: A Single Center Retrospective Study
Carlen Yuen, Pankti Reid, Zuoli Zhang, et al.
Cancers
|
June 2, 2021
STING Agonists as Cancer Therapeutics
Afsaneh Amouzegar, Manoj Chelvanambi, Jessica N Filderman, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
January 13, 2019
WNT/β-catenin Pathway Activation Correlates with Immune Exclusion across Human Cancers
Jason J Luke, Riyue Bao, Randy F Sweis, et al.
Page
of 19
Search research articles
Search
Showing results (41-50 of 185) with videos related to
Sort By:
Page
of 19
Frontiers in Immunology
|
April 19, 2021
High Throughput Multi-Omics Approaches for Clinical Trial Evaluation and Drug Discovery
Jessica M Zielinski, Jason J Luke, Silvia Guglietta, et al.
Journal for Immunotherapy of Cancer
|
June 23, 2016
Single dose denileukin diftitox does not enhance vaccine-induced T cell responses or effectively deplete Tregs in advanced melanoma: immune monitoring and clinical results of a randomized phase II trial
Jason J Luke, Yuanyuan Zha, Karen Matijevich, et al.
Cancer Immunology Research
|
September 6, 2018
T Cell-Inflamed versus Non-T Cell-Inflamed Tumors: A Conceptual Framework for Cancer Immunotherapy Drug Development and Combination Therapy Selection
Jonathan A Trujillo, Randy F Sweis, Riyue Bao, et al.
Nature Reviews. Clinical Oncology
|
April 5, 2017
Targeted agents and immunotherapies: optimizing outcomes in melanoma
Jason J Luke, Keith T Flaherty, Antoni Ribas, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
January 18, 2024
Facts and Hopes in Using Omics to Advance Combined Immunotherapy Strategies
Ryan C Augustin, Wesley L Cai, Jason J Luke, et al.
Nature Reviews. Clinical Oncology
|
April 26, 2022
Optimal systemic therapy for high-risk resectable melanoma
Alexander M M Eggermont, Omid Hamid, Georgia V Long, et al.
International Journal of Breast Cancer
|
June 5, 2018
The Evolution of Radiation Therapy in Metastatic Breast Cancer: From Local Therapy to Systemic Agent
Jessica M S Jutzy, Jeffrey M Lemons, Jason J Luke, et al.
Journal of Immunotherapy (Hagerstown, Md. : 1997)
|
January 8, 2019
Facial Palsy Induced by Checkpoint Blockade: A Single Center Retrospective Study
Carlen Yuen, Pankti Reid, Zuoli Zhang, et al.
Cancers
|
June 2, 2021
STING Agonists as Cancer Therapeutics
Afsaneh Amouzegar, Manoj Chelvanambi, Jessica N Filderman, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
January 13, 2019
WNT/β-catenin Pathway Activation Correlates with Immune Exclusion across Human Cancers
Jason J Luke, Riyue Bao, Randy F Sweis, et al.
Page
of 19